Gene: IGFL1
Official Full Name: IGF like family member 1provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the insulin-like growth factor family of signaling molecules. The encoded protein is synthesized as a precursor protein and is proteolytically cleaved to form a secreted mature peptide. The mature peptide binds to a receptor, which in mouse was found on the cell surface of T cells. Increased expression of this gene may be linked to psoriasis. [provided by RefSeq, Aug 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16982 | IGFL1 Knockout cell line (HeLa) | Human | IGFL1 | 1:3~1:6 | Negative | Online Inquiry |
KO16983 | IGFL1 Knockout cell line (A549) | Human | IGFL1 | 1:3~1:4 | Negative | Online Inquiry |
IGFL1 Gene Knockout Cell Lines are genetically engineered cell lines in which the Insulin-like Growth Factor (IGF) Ligand 1 gene has been specifically disrupted or "knocked out". This innovative tool allows researchers to study the biological functions of IGFL1 by observing the resulting phenotypic changes in cellular responses and signaling pathways. By removing the IGFL1 gene, these cell lines enable scientists to investigate its role in key biological processes, including cell proliferation, differentiation, and metabolic regulation, providing a deeper understanding of its contribution to both normal and pathological states.
The primary function of IGFL1 involves its interaction with IGF receptors, which play crucial roles in mediating cellular growth and development. Understanding how the absence of IGFL1 affects these interactions can illuminate its involvement in diseases such as cancer and metabolic disorders. IGFL1 gene knockout cell lines stand as a crucial resource in elucidating these pathways, allowing researchers to perform loss-of-function studies that can uncover new therapeutic targets or treatments.
Scientifically, the availability of IGFL1 gene knockout cell lines holds significant importance in both academic and clinical settings. Researchers can utilize these cell lines to develop and test novel hypotheses about IGF signaling and its implications in various diseases. Furthermore, these knockouts can serve as a benchmark for high-throughput drug screening, enhancing the predictive accuracy of pharmacological studies.
What sets our IGFL1 Gene Knockout Cell Lines apart from alternatives is their exceptional specificity and reliability, ensured by our rigorously validated knockout process. Unlike conventional cell lines or less tailored knockout models, our product is designed to minimize off-target effects and provides reproducible results. This makes it a superior choice for researchers seeking to derive meaningful insights with confidence.
Investing in IGFL1 Gene Knockout Cell Lines not only supports innovative research but also paves the way for groundbreaking discoveries that have the potential to transform clinical applications. By utilizing our high-quality biological products, researchers and clinicians can accelerate their projects with reduced variability and increased reproducibility.
Our company proudly specializes in the development and provision of advanced genetic research tools, backed by state-of-the-art technology and expertise in cell line engineering. With a commitment to quality and innovation, we empower scientific inquiry that drives tomorrow’s breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.